ロード中...
Combination approaches in NSCLC involving immune checkpoint inhibitors
Immune checkpoint inhibition has been proven to be highly efficacious in NSCLC and associated with durable responses in a limited number of patients. Chemotherapy and targeted therapies, which have also expanded rapidly in this field lead to high response rates and improved survival although inevita...
保存先:
| 出版年: | Lung Cancer Manag |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Future Medicine Ltd
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6310331/ https://ncbi.nlm.nih.gov/pubmed/30643561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/lmt-2016-0013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|